Tumor Evolution & Clonal Architecture
Reconstructing intra-tumor heterogeneity, subclonal phylogenies, and temporal ordering of somatic events using high-depth whole-genome sequencing (WGS).
Research interests, technical skills, and the tools behind them.
Analysis pipelines are published on GitHub at github.com/Sejung98.
Investigating tumor evolutionary dynamics, structural variations, and multi-omics prognostication through rigorous computational genomics and functional biology.
Reconstructing intra-tumor heterogeneity, subclonal phylogenies, and temporal ordering of somatic events using high-depth whole-genome sequencing (WGS).
Characterizing complex genomic rearrangements, whole-genome doubling (WGD), and cryptic structural alterations using Oxford Nanopore and PacBio long-read platforms.
Building predictive clinical risk models and prioritizing therapeutic biomarkers by integrating multi-omics profiles (genomics, transcriptomics, epigenomics) in breast and ovarian cancers.
Bridging high-throughput in silico pipelines with wet-lab experimental validation and patient cohorts to identify actionable clinical vulnerabilities.
Integrated stack spanning computational bioinformatics, statistical modeling, and pipeline engineering.
End-to-end processing of WGS, WES, RNA-seq, and long-read datasets (Oxford Nanopore, PacBio). Personally configured and established the Hartwig Medical Foundation (HMF) whole-genome pipeline in our laboratory, actively running comprehensive tumor genomic analyses using Nextflow.
Clonal deconvolution, subclonal clustering (PyClone, SciClone), tumor phylogenetic tree reconstruction (PhylogicNDT), and temporal ordering of driver events.
Cox proportional hazards, Kaplan-Meier estimation, regularized regression (Lasso/ElasticNet), multi-omics integrative clustering, and robust clinical biomarker prioritization.
Scalable pipeline execution on Linux / HPC clusters (SLURM). Python & R data science ecosystems, Git / GitHub version control, and containerized workflows with Nextflow & Docker.
Mammalian cell culture, flow cytometry (FACS), Western blotting, ELISA, cytokine multiplex assays, and murine disease models for validating in silico predictions.